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Long term mortality with cardiac
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Background: Randomized clinical trials demonstrated that car-
diac resynchronization therapy (CRT) improves survival in pa-
tients with congestive heart failure. The data of survival in
patients treated in naturalized practice is sparse and no data is
available from India.
Methods: The clinical and device data of patients who had un-
dergone CRT implantation at least 5 years before were analyzed.
Results: The follow up data is available from 61 patients out of
total 78 patients who have had CRT atleast 5 years before. The
mean follow up period was 7.5 (range 5 e 12) years.There were 44
(72%)males. The mean age was 58 ±13 (range 29 e 67) years. None
of the patients had AICD indication for secondary prevention of
sudden cardiac death and all of them were in NYHA class III.
Coronary angiography was normal at the time of implant in 61%
(N¼ 37). Thirteen patients (21%) have died.Nine (70%) patients had
ischemic heart disease. On the basis of the clinical records and
device data, the cause of death was considered sudden in six (46%)
patients. All of the patients who have died had documented AF
and renal dysfunction.
Conclusion: Atleast one in five patients with CRT die over a follow
up period of 5 years and nearly half of the deaths are sudden.
Renal dysfunction and atrial fibrillation are themarkers of highest
risk.
Valvular Heart Disease (RHD)
Rheumatic heart disease in Kerala e A vanishing
entity? An echo Doppler study in 5e15 years old
school children (2013e2014)
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Objective: To study the prevalence of Rheumatic heart disease
using echo Doppler in School Children of Trivandrum.
Methods: A total of 2060 students aged 5 e 15 years from five
Government (1023) and two private schools (aided) (1037) were
screened. Schools were randomly selected. All children and
parents in each school were informed regarding the study,
consent forms sent home through children. Children with
informed written consent from parents were included in study.
Subjects were interviewed using a proforma, a detailed clinical
examination and echo Doppler study using Philips (HD-11)
machine in schools. World heart federation 2012 criteria were
used to identify RHD children. Data analysed using SPSS
software.
Results: Of all 2060 children, 64.8% were males and 35.2% were
females and mean age was 12.6 ± 2.1years. Clinical examination
detected murmur in 184 subjects, of which 32 (17.4%) subjects
detected to have a heart disease by echocardiographic evaluation.
Out of 45 subjects with apical systolic murmur, 5(11.1%) subjects
had RHD by echocardiography, clinical prevalence being 2.4/1000
(95%CI 1.1-4.2). Clinical prevalence of RHD (by h/o of rheumatic
fever and clinical apical systolic murmur was found in one child)
to be 0.49 /1000(95% CI 0-1.4).
All subjects underwent echo Doppler evaluation. Echo Doppler
evaluation diagnosed RHD in 12 children, of which 6 children had
definite RHD, 6 had borderline RHD by WHF criteria, giving a
prevalence of 5.83 /1000 (95%CI 2.5-9.1) school children. Definite
RHD byWHF criteria was 2.9 /1000 school children. Anteriormitral
valve thickness>3mm and mitral regurgitation waspresent in all.
Aortic regurgitation was seen in five school children by echo.
Mitral regurgitation was grade 1 in 140 children and grade 2 in 6
children. None had severe MR by echo or hemodynamically sig-
nificant MR. Of 146 children with mitral regurgitation, 24 children
had apical systolic murmur. Anterior mitral leaflet prolapse sug-
gestive of rheumatic etiology with pathological MR seen in 3
children. None of the subjects had commissural fusion and mitral
stenosis. Two children had history of acute rheumatic fever on
secondary prophylaxis, of which one had history of rheumatic
chorea.
Conclusion: It is the first and largest school survey study in Kerala
for Rheumatic heart disease using echo Doppler till date. Echo
prevalence of RHD was several folds higher compared to clinical
prevalence. Our study suggest that RHD prevalence by echo
Doppler is less in Kerala(5.83/1000), due to its better socioeco-
nomic living standards, better health indices, availability of
prompt medical care and less overcrowding(4.4±1comparedwith
6.4± 2.3, RHEUMATICstudy, Delhi) and higher literacy rates among
females.
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Background: Beta-blockers are frequently used in patients with
mitral stenosis to control the heart rate and alleviate exercise-
related symptoms. The objective of our study was to examine
whether ivabradine was superior to atenolol for achieving higher
exercise capacity in patients withmoderatemitral stenosis (MS) in
sinus rhythm. We also evaluated their effects on left ventricular
myocardial performance index (MPI).
Methods and Results: Eighty-two patients with moderate mitral
stenosis in sinus rhythm were randomized to receive ivabradine
(n¼42) 5 mg twice daily or atenolol (n¼40) 50 mg daily for 6
weeks. Trans-thoracic echocardiography and treadmill test were
performed at baseline and after completion of 6 weeks of treat-
ment. Mean total exercise duration in seconds markedly
improved in both study groups at 6 weeks (298.57±99.05sec vs.
349.12±103.53sec; p¼0.0001 in ivabradine group, 290.90± 92.42 sec
vs. 339.90± 99.84sec; p¼0.0001in atenolol group). On head to head
comparison, there was no significant change in improvement of
exercise time between ivabradine and atenolol group (p¼0.847).
Left ventricular myocardial performance index did not show any
significant change from baseline and at 6 weeks in both drug
groups (49.8 ± 8% vs. 48.3± 7% in ivabradine group, 52.9± 10% vs.
50.9± 10% in atenolol group; p¼0.602).
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Conclusion: Ivabradine or atenolol can be used for heart rate
control in moderate MS patients in sinus rhythm. Ivabradine is
not superior to atenolol for controlling heart rate or exercise ca-
pacity. Left ventricular MPI was unaffected byeither of the drugs.
Outcome of percutaneous balloon mitral
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Background: Percutaneous balloon mitral valvotomy (PBMV) is
well established as a safe and effective alternative to mitral ste-
nosis surgery, but only a few small studies have been reported on
the procedure. The aim of this study is to assess the safety, effi-
cacy and outcome of PBMV in Shahid Gangalal National Heart
Centre, Kathmandu, Nepal.
Methods: 262 consecutive patients who underwent balloon val-
votomy for moderate to severe mitral stenosis between July 1st
2013 to June 31st 2014 in our centre were analyzed.
Results: Among 262 patients, 74% percent of the patients were
females. Their age range was from 10years to 76years and mean
age was 33.2years. 70 (26.7%) patients were in atrial fibrillation; 6
(2%) patients were pregnant; 3 (1%) patients had Cerebrovascular
Accident; 12 (4.6%) patients underwent previous surgical or
balloon commissurotomy. The procedural success was achieved
in 84% patients. The mean left atrial pressure was reduced from
26.8 ± 8.9 mmHg to 15.6 ± 7.2 mmHg (p < 0.05).The mean mitral
valve area assessed by 2-D echocardiography increased from 0.9 ±
0.17 cm2 to 1.6 ± 0.28 cm2 (p < 0.05). 49 patients (18.7%) developed
moderate to severe mitral regurgitation. There was no mortality
related to the procedure.
Conclusion: The results of this study show that PBMV is a safe
procedure with good success rate for symptomatic mitral stenosis
with low complication rates and good clinical improvement.
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Background: Mitral stenosis is one of the most frequently
encountered cardiac abnormalities in women of child- bearing
age, accounting for nearly 90% of the cases of rheumatic heart
disease associated with pregnancy. This study was done to eval-
uate the safety and effectiveness of percutaneous balloon mitral
valvuloplasty (BMV) with severemitral stenosis during pregnancy.
Methods: A total of 30 pregnant patients were included in the study
after detailed echocardiographic evaluation. Clinical and echocar-
diographic follow-up were done by hospital visits every 3 months
after the procedure until delivery and at 6 months follow up.
Results: 14 (46.67%) patients underwent BMV during the third
trimester of pregnancy, whereas 16 (53.3%) had the procedure
performed in the second trimester. Mean gestational Age at the
time of procedure was 25.3 ± 3.93 weeks. 2 (6.6%) were in NYHA
class IV, 14 (46.7%) were in III and the remaining 14 (46.7%) of
patients were in NYHA class II.19 (63.33%) patients had a Wilkin’s
score of <8, and 11 (36.67%) had a score of >8. 29(96.3%) patients
had moderate or severe pulmonary artery hypertension, with
mean Pulmonary artery systolic pressure 68.23±23.28
mmHg.There was no maternal mortality. One patient developed
severe mitral regurgitation which underwent successful emer-
gency surgical mitral valve replacement. No patient had cere-
brovascular stroke/TIA or any vascular complications. The mean
mitral valve area was 0.85+0.16 cm2 before BMV and increased to
1.60+0.27 cm2 (p<0.0001) immediately after BMV. Peak and mean
diastolic gradients had decreased significantly 48 hours after the
procedure (p<0.001) but remained very much unchanged at 6.72
month follow-up compared with post procedure values .Two pa-
tients had an increase in mitral regurgitation by 2 grades. The
mean follow up duration was 6.72±0.56 months. 3 (11.11 %)
delivered before term.7 (25.91%) babies were having birth weight
less than 2.5 kg.
Conclusion: This study further supported the impression that
BMV was the procedure of choice to treat pregnant women with
rheumatic mitral stenosis in NYHA class II to IV. In this popula-
tion, BMV was a safe and effective procedure that resulted in
excellent immediate and intermediate-term outcomes for
mothers and their offspring.
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Background: Prosthetic heart valve thrombosis (PHVT) occurs
frequently in developing countries and causes major morbidity
andmortality. The study was done to evaluate clinical, laboratory,
and diagnostic profile of patients admitted in emergency room
with obstructive PHVT and to study efficacy, outcomes and com-
plications of thrombolytic therapy and surgical therapy for
obstructive PHVT.
Methods: A total of 82 patients with PHVT in form of acute or sub-
acute dyspnoea (<1 month) or embolic phenomena were enrolled
and confirmed with either transthoracic or trans oesophageal
echo and cine fluoroscopy and were followed up for 2 years.
Results: 29.27% patients were adequately anticoagulated on
admission while 70.73% patients were not. 97.6% cases involved
mitral while 2.4% cases involved aortic prosthesis. 94% cases had
normal left ventricular function on admission, and 91% cases had
moderate to severe pulmonary artery hypertension. Treatment
option was chosen on basis of clinical characteristics, thrombus
load, affordability, patient’s and surgeon’s preference. 67 (81.7%)
patients were treated with thrombolysis by streptokinase (88%) or
urokinase (12%), and 12(14.6%) patients undergone surgery,
3(3.6%) patients undergone surgery after failed thrombolysis. In
thrombolysis group, complete success rate was 67.16%, mortality
rate was 14.92 %, recurrence rate at 2-yr follow up was 11.94%,
while in surgery group complete success rate was 92.3%,mortality
rate was 7.7%, recurrence rate at 2-yr follow up was 23.07%.
Conclusion: Compared to surgical therapy, thrombolysis in pa-
tients with PHVT was found to have higher mortality and
complication rates but with lower recurrence rates of valve
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